ArticleMicromachines2024
Quick-Delivery Mold Fabricated via Stereolithography to Enhance Manufacturing Efficiency.
Article in Micromachines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineering the Future of Heart Failure Therapeutics: Integrating 3D Printing, Silicone Molding, and Translational Development for Implantable Cardiac Devices.Bioengineering (Basel, Switzerland) · 2026Article
- Research on a New Method of Macro-Micro Platform Linkage Processing for Large-Format Laser Precision Machining.Micromachines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The ever-growing demand for reducing costs and decreasing the time to market in today's plastics industry makes rapid tooling and rapid prototyping highly researched areas. Stereolithography (SLA)-manufactured injection mold inserts make it possible to produce prototype parts rapidly and cost-effectively. To utilize SLA in the injection molding industry, two steps have to be considered. The first is to identify suitable SLA process and post-thermal curing process parameters to enhance the mechanical and thermal characteristics. The second is to verify the applicability of SLA-manufactured molds for use in the injection molding industry. IA comprehensive study was performed to find the optimum process parameters for an SLA mold with excellent mechanical and thermal properties and to verify the applicability of the mold. First of all, the mechanical and thermal properties of samples manufactured based on various laser powers and heat treatment at different temperatures were analyzed with a tensile test, DSC, and TMA according to the degree of cure. On the basis of the results from those tests, an SLA mold was designed and fabricated with the optimum mechanical and thermal properties. In addition, the SLA mold was assembled into an injection machine, and an injection molding test was conducted. The SLA mold endured during the injection cycle, and 500 shots were successfully injected without damaging the mold, which resulted in reaching the quick-delivery mold standard. Finally, we demonstrate that SLA is an effective technology to produce molds for use in the injection molding industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.